Institut Pasteur Korea



Institut Pasteur Korea was created on 29 December 2003 and inaugurated on 12 April 2004. It is the fruit of a collaboration between the Institut Pasteur in Paris and the Korean Institute of Science and Technology (KIST) in Seoul. IP Korea joined the Institut Pasteur International Network in November 2004 as a private foundation working toward the public good.
 


Institut Pasteur Korea was created based on the concept "from genes to medicines," and has created high content screening platform that brings together the latest research in biology, technology and chemistry.

Disease Models:

Malaria                                 Dengue
HIV                                        Tuberculosis
Hepatitis                              Cancers
Leishmania                         Diabetes
Chagas                                Neurodegeneration

Technology:

PhenomicScreen™ :target-free visual high content screening to identify chemical compounds that prevent or slow disease progression in live, physiologically relevant disease models.

PhenomicID™ : high-content genome-wide visual arrays to identify targets of interest in live cellular disease models by screening with siRNA libraries.

Medicinal Chemistry:  applying new concepts of drug design to optimize hit to lead identification.